ABSTRACT Aim: Compared to infants born at term, children born very preterm are at increased risk of visual dysfunctions and neonatal systemic inflammation. Here, we explore whether these two propensities are related.
INTRODUCTION
Compared to infants born near term, preterm newborns are at increased risk of visual problems such as visual field deficits (VFDs) (1) , delayed development of smooth pursuit (2) and strabismus (3) . Inflammation appears to contribute to both preterm birth (4) , and in children born preterm, to impaired brain functions (5) , retinopathy of prematurity (ROP) (6) and cerebral visual impairment (CVI) (7) .
Abbreviations CRP, C-reactive protein; CVI, Cerebral visual impairment; ELGAN, Extremely Low Gestation Age Newborn; EPO, Erythropoietin; ICAM-1, Intercellular attracting molecule-1; IL-1b, Interleukin-1b; IL-6, Interleukin-6; IL-6R, Interleukin receptor; IL-8, Interleukin-8; MMP-9, Matrix metalloproteinase-9; MPO, Myeloperoxidase; RANTES, Regulated upon activation, normal T cell expressed and secreted; ROP, Retinopathy of prematurity; SAA, Serum amyloid A; TNFR2, Tumour necrosis factor receptor; TNF-a, Tumour necrosis factor-a; TSH, Thyroid-stimulating hormone; VEGFR-2, Vascular endothelial growth factor receptor-2; VEGF, Vascular endothelial growth factor; VFD, Visual field deficit.
Key notes
Visual field deficits, strabismus, and impaired fixation are more common in children born preterm compared to children born at term. These dysfunctions often accompany motor dysfunctions such as cerebral palsy, which is associated with early systemic inflammation. Among 2-year-old children born before the 28th week of gestation, we did not find that visual field deficits, strabismus, and impaired fixation to be associated with systemic inflammation during the first postnatal month.
Cytokines in blood can be a marker of antenatal exposure to maternal infection (8) , as well as an indicator of postnatal infection in preterm infants (9) . Although many of the harmful effects of pre-and postnatal inflammation are known, the role of peripheral blood mediators of inflammation in neuro-ophthalmological development remains unclear. The Extremely Low Gestational Age Newborn (ELGAN) study was specifically designed to identify molecular antecedents along with clinical characteristics and exposures that increase the risk of structural and functional neurological disorders in infants born extremely preterm (10) . Here, we explore the relationships of visual field deficits, strabismus and impaired ability to visually fixate at two-year corrected age with blood concentrations of 16 cytokines and growth factors associated with inflammation during the first postnatal month.
PATIENTS AND METHODS

Participants
During the years 2002-2004, women who gave birth before 28th week of gestation at one of 14 participating hospitals in five states in the USA were asked to enrol in the ELGAN study. The individual institutional review boards approved the enrolment and consent processes. Mothers were approached for consent either upon antenatal admission or shortly after delivery. The analyses in this report are based on the data of 1062 infants who had protein concentrations measured in blood obtained during the first four postnatal weeks and had a developmental assessment at two-year corrected age.
Proteins measured
We measured the following 16 proteins: C-reactive protein (CRP), serum amyloid A (SAA), myeloperoxidase (MPO), interleukin-1b (IL-1b), interleukin-6 (IL-6), interleukin-6 receptor (IL-6R), tumour necrosis factor-a (TNF-a), tumour necrosis factor receptor 2 (TNFR2), interleukin-8 (IL-8; CXCL8), regulated upon activation, normal T cell expressed and secreted (RANTES; CCL5), intercellular adhesion molecule-1 (ICAM-1; CD54), matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor-2 (VEGFR-2; KDR), thyroid-stimulating hormone (TSH) and erythropoietin (EPO).
Developmental assessment at 24 months Eighty-five per cent of surviving children were assessed close to 24-month corrected age, and 77% had their exam within the range of 23.5-27.9 months. Most others were examined before 23.5 months. Procedures to standardise the neurological examination and minimise examiner variability are presented elsewhere (11) . Visual interaction was assessed under the child's optimal state of wakefulness and cooperation. Visual fields were assessed by binocular confrontation, and deficits were identified in 62 children. Testing required that the child initially maintained a fixed gaze straight ahead on a target item.
The examiner then brought a brightly coloured item into one of the child's four visual fields. Visual field was considered to be intact if the child moved the gaze from the target straight ahead to the object coming into the quadrant field assessed. The child's success or failure to see an object in each of the four quadrants of the visual field was recorded. If he or she did not attend to the moving stimulus, the evaluation was repeated to confirm the result. The ability to fixate and follow faces and toys was recorded as present or absent by binocular testing. The child was considered to have impaired fixation if s/he could not fixate even briefly (N = 60), or could not sustain eye contact long enough to follow the examiner across the midline (N = 62). Every child was assessed for strabismus causing dysconjugate gaze using cover/uncover testing. Esotropia or exotropia in each eye was recorded. Esotropia and exotropia were defined as an eye that exhibited either convergent or divergent strabismus, respectively. A total of 129 children were identified as having strabismus, 26 had esotropia only, 101 exotropia only and two had both esotropia and exotropia.
Data analyses
We evaluated the generalised null hypothesis that having a visual field deficit, impaired fixation or/and strabismus was not associated with any blood protein concentration in the highest quartile for gestational age on any of the five days blood was collected. We also explored whether a prolonged/sustained inflammation was associated with an increased risk compared to inflammation on a single day. Early sustained inflammation was defined as a protein concentration in the top quartile on two or more of the first three protocol days (1, 7 and 14) , and late sustained inflammation was defined as being in the top quartile on both of the last two protocol days (21 and 28). Assessments for sustained/recurrent inflammation were restricted to children who had blood collected in multiple days in each of the early and late intervals.
We created logistic regression models to evaluate each biomarker individually. The models were adjusted for gestational age category (23-24, 25-26, 27 weeks) and birth weight Z-score <À2 to control for foetal growth restriction. These models allowed us to calculate odds ratios (OR) and 99% confidence intervals (CIs). A 99% CI (p < 0.01) was selected to adjust the analyses for multiple comparisons.
RESULTS
Visual field deficit
An elevated concentration of the neutrophil activation marker, myeloperoxidase (MPO) on day 14 was associated with a visual field deficit (OR 2.2, CI: 1.1, 4.7) (Table S1 ). When the analyses were restricted to children who had blood spots available on multiple days, no early (days 1, 7, and 14) or late (days 21 and 28) recurrent or sustained protein elevation was associated with VFD.
Visual fixation impairment
An ICAM-1 (CD54) concentration in the highest quartile on day 14 (OR 2.4, CI 1.2, 4.9) was the only protein elevation associated with an increased risk of impairment in visual fixation (Table S2 ). Among children who had blood spots available from multiple days, no early (days 1, 7, and 14) or late (days 21 and 28) single day or recurrent or sustained protein elevation was associated with impaired fixation.
Strabismus
No single day protein elevation, and no early or late single day or recurrent/sustained elevation was associated with an increased risk of strabismus (Table S3) .
DISCUSSION
We did not find neonatal systemic inflammation during the first four postnatal weeks to be a prominent antecedent of any of the three neuro-ophthalmologic dysfunctions assessed at age two years. As our analyses include 240 comparisons (five days 9 16 proteins 9 three neuroophthalmologic disorders), we interpret our two statistically significant findings as random phenomena. These findings are in contrast to the associations found between early postnatal systemic inflammation and brain function and structure abnormalities at age two years in the ELGAN Study sample, including impaired neurodevelopment (12), microcephaly (13) , and cerebral palsy (14) . Because children with each of these dysfunctions/disorders are at increased risk of visual field deficits, impaired fixation, and strabismus (15, 16) , one might expect to find early systemic inflammation to be a risk factor for visual impairments. In what follows, we offer possible explanations as to why we did not find such an association.
First, it is possible that peripheral blood concentrations of markers of inflammation in the neonatal period do not reflect the potential harmful events that the foetus has experienced in utero. From this perspective, measurements of inflammatory biomarkers in amniotic fluid or cord blood might be better than postnatal blood for predicting later complications in the preterm population. Indeed, elevated concentrations of various cytokines in the cord blood of preterm newborns were associated with increased risk of cerebral lesions (17) , cerebral palsy (18) and neonatal morbidity and mortality (19) . The ELGAN Study, however, did not obtain cord blood, but the day 1 blood was collected hours after birth. These day 1 measurements were not as predictive as cytokine elevations in blood obtained on days 7 and 14 (12) (13) (14) . Consequently, we consider it likely that the collected blood specimens are likely to provide the most relevant information about systemic inflammation.
Second, the interrelationships between the inflammatory stimulus, the infant's inflammatory response and later damage are complex (12) . In rat models, inflammation represents a sensitising or preconditioning process for the preterm brain (20) , and a two-hit model has been proposed for brain damage in preterm infants (21) . Consequently, our failure to adequately document prior episodes of inflammation and other processes that might have influenced the risk of neuro-ophthalmological dysfunctions might account for our not finding a strong inflammatory signal associated with strabismus, visual field deficits or impaired fixation.
Third, our results represent snapshots of select biomarkers. It is possible that we either missed changes in cytokine concentrations that happened in between our measuring points or we did not measure the biomarkers that might have contributed to, or been markers of the processes leading to the neuro-ophthalmologic dysfunctions we assessed. Still, to our knowledge, the biomarkers we measured are among those closely related to perinatal brain damage (9) .
Our study has several strengths. First, we included a large number of infants, making it unlikely that we have missed important associations due to lack of statistical power, or claimed associations that might have reflected the instability of small numbers. Second, we selected infants based on gestational age, not birth weight, in order to minimise confounding due to factors related to foetal growth restriction (22) . Third, we collected all of our data prospectively, and the methods used are highly reliable. Our study also has some limitations. Perhaps most important is that a neuroophthalmologic assessment at age two years is not as revealing as an assessment at older ages (23) . We acknowledge that more accurate testing at an older age can provide better estimates of the extent of visual deficits.
CONCLUSION
In conclusion, systemic inflammation in very preterm newborns does not appear to contribute appreciably to the occurrence of visual field deficits, impaired visual fixation or strabismus assessed at age two years.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article: Table S1 Odds ratios (and 99% confidence intervals) of having a visual field deficit among children whose concentration of the protein listed on the left was in the top quartile for gestational age category and day blood was obtained compared to children in the lower 3 quartiles. Table S2 Odds ratios (and 99% confidence intervals) of impaired fixation among children whose concentration of the protein listed on the left was in the top quartile (for gestational age category and day blood was obtained) compared to children in the lower 3 quartiles. Table S3 Odds ratios (and 99% confidence intervals) of strabismus among children whose concentration of the protein listed on the left was in the top quartile (for gestational age category and day blood was obtained) compared to children in the lower 3 quartiles. Appendix S1 Supplemental methods.
